104 NeadK
While Semaglutide activates only the GLP-1 receptor, Tirzepatide activates both GLP-1 and GIP (Glucose Dependent Insulinotropic Polypeptide) receptors, leading to more profound metabolic and appetite-suppressing effects
A physician can tell you what fits your budget and health
Discussion ECM acts as a fundamental scaffold, orchestrating the structural integrity and mechanical resilience of the lungs in both homeostasis and disease 43
if you become pregnant whilst on treatment, stop the medication and seek immediate medical and nutritional review [1] [25] Contact your GP urgently if you experience: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Upper-right abdominal pain, fever or jaundice which may suggest gallbladder disease Persistent nausea or vomiting preventing adequate nutrition Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained symptoms such as jaundice, severe fatigue, or mood changes For people with diabetes: hypoglycaemia (low blood sugar) symptoms when taking insulin or sulfonylureas alongside GLP-1 therapy Regular monitoring throughout GLP-1 treatment should include periodic assessment of weight, body composition where possible, nutritional intake, and relevant blood markers
